CV Sciences, Inc. (OTCMKTS:CVSI) Sees Large Growth in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 67,700 shares, a growth of 145.3% from the March 31st total of 27,600 shares. Based on an average trading volume of 530,200 shares, the days-to-cover ratio is presently 0.1 days.

CV Sciences Stock Down 5.0 %

CV Sciences stock traded down $0.00 during midday trading on Friday, hitting $0.04. 78,205 shares of the stock were exchanged, compared to its average volume of 221,877. The company has a fifty day simple moving average of $0.04 and a two-hundred day simple moving average of $0.04. CV Sciences has a 52 week low of $0.03 and a 52 week high of $0.06. The stock has a market capitalization of $6.15 million, a PE ratio of 1.99 and a beta of 0.62.

CV Sciences (OTCMKTS:CVSI) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($0.01) earnings per share for the quarter. CV Sciences had a net margin of 19.38% and a return on equity of 80.98%. The company had revenue of $3.80 million during the quarter.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.